PURPOSE: To distinguish between contributions to dementia made by homocysteine, folate, B12 and antioxidant micronutrients. METHODS: This is a follow-up study of a sample reported in 2002. Homocysteine was measured at baseline in 201 individuals born in 1921 and without dementia at age 77 years and followed up to age 88 years. Baseline macro- and micronutrient status was estimated from BMI, the MONICA food frequency questionnaire, plasma folate, B12 and, in a subgroup (N = 173), plasma antioxidant micronutrients. Time to dementia onset during follow-up was compared between participants grouped by homocysteine concentration using Cox regression. Model 1 adjusted for age, sex, childhood IQ, education, socioeconomic deprivation, presence of heart disease, hypertension, plasma folate and B12. In model 2 plasma, antioxidants were added to these covariables. RESULTS: During a mean follow-up of about 5 years, there were 39 incident dementia cases among 201 participants. In model 1, being in the highest homocysteine group (>14 μmol/L) was associated with a 234 % increased risk (HR 3.34, 95 % CI 1.16-9.57) of any dementia. After inclusion of plasma antioxidants in model 2, there were 32 incident dementia cases from a subsample (N = 173). Homocysteine >14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08). CONCLUSIONS: High homocysteine increases the risk of dementia. The association between tHcy and dementia is independent of plasma folate, B12 and antioxidant micronutrient status.
PURPOSE: To distinguish between contributions to dementia made by homocysteine, folate, B12 and antioxidant micronutrients. METHODS: This is a follow-up study of a sample reported in 2002. Homocysteine was measured at baseline in 201 individuals born in 1921 and without dementia at age 77 years and followed up to age 88 years. Baseline macro- and micronutrient status was estimated from BMI, the MONICA food frequency questionnaire, plasma folate, B12 and, in a subgroup (N = 173), plasma antioxidant micronutrients. Time to dementia onset during follow-up was compared between participants grouped by homocysteine concentration using Cox regression. Model 1 adjusted for age, sex, childhood IQ, education, socioeconomic deprivation, presence of heart disease, hypertension, plasma folate and B12. In model 2 plasma, antioxidants were added to these covariables. RESULTS: During a mean follow-up of about 5 years, there were 39 incident dementia cases among 201 participants. In model 1, being in the highest homocysteine group (>14 μmol/L) was associated with a 234 % increased risk (HR 3.34, 95 % CI 1.16-9.57) of any dementia. After inclusion of plasma antioxidants in model 2, there were 32 incident dementia cases from a subsample (N = 173). Homocysteine >14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08). CONCLUSIONS: High homocysteine increases the risk of dementia. The association between tHcy and dementia is independent of plasma folate, B12 and antioxidant micronutrient status.
Authors: Scott M Smith; Susan A Mathews Oliver; Sara R Zwart; Geeta Kala; P Adam Kelly; James S Goodwin; Carmel B Dyer Journal: J Nutr Date: 2006-10 Impact factor: 4.798
Authors: Celeste A de Jager; Abderrahim Oulhaj; Robin Jacoby; Helga Refsum; A David Smith Journal: Int J Geriatr Psychiatry Date: 2011-07-21 Impact factor: 3.485
Authors: Susan J Duthie; Lawrence J Whalley; Andrew R Collins; Steve Leaper; Kerstin Berger; Ian J Deary Journal: Am J Clin Nutr Date: 2002-05 Impact factor: 7.045
Authors: Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler Journal: JAMA Date: 2002-06-26 Impact factor: 56.272
Authors: Jorge A Serra; Raúl O Domínguez; Enrique R Marschoff; Eduardo M Guareschi; Arturo L Famulari; Alberto Boveris Journal: Neurochem Res Date: 2009-12 Impact factor: 3.996
Authors: Jeffery M Reddan; David J White; Helen Macpherson; Andrew Scholey; Andrew Pipingas Journal: Front Aging Neurosci Date: 2018-03-07 Impact factor: 5.750
Authors: A David Smith; Helga Refsum; Teodoro Bottiglieri; Michael Fenech; Babak Hooshmand; Andrew McCaddon; Joshua W Miller; Irwin H Rosenberg; Rima Obeid Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472